Dopamine receptor D1 and D2 (DRD1/DRD2)

Dopamine receptors D1 and D2 are the primary mediators of dopaminergic neurotransmission in the central nervous system, belonging to the G protein-coupled receptor (GPCR) superfamily. The D1 receptor is the most abundant dopamine receptor in the brain and typically exerts excitatory effects by stimulating cAMP production, playing a critical role in locomotor activity, memory, and reward. In contrast, the D2 receptor typically exerts inhibitory effects and is the principal target for nearly all clinically effective antipsychotic drugs, which generally act as antagonists to mitigate positive symptoms of schizophrenia. These receptors are also central to the pathology and treatment of Parkinson's disease, where dopamine depletion leads to motor deficits that are managed using D2-preferring agonists or dopamine precursors. Beyond motor and cognitive functions, D2 receptors in the pituitary gland regulate the secretion of prolactin, making them relevant in endocrine disorders. The balance between D1-mediated and D2-mediated signaling is essential for normal neurological function, and dysregulation is implicated in a wide range of neuropsychiatric and movement disorders.

Other names

D1 dopamine receptorD2 dopamine receptorD1RD2RDopamine D1 receptorDopamine D2 receptor

D1 receptors primarily couple to Gs proteins to stimulate adenylyl cyclase and increase cAMP levels, while D2 receptors couple to Gi/o proteins to inhibit adenylyl cyclase and decrease cAMP levels. Drugs act as agonists to restore dopaminergic signaling or as antagonists/partial agonists to modulate overactive pathways.